Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Smiles
COc1ccc2c(=O)c(coc2c1OC)c3cc(c(cc3I)OC)OC
Field Of Use
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Cas Number
12772-57-5
Molecular Weight
364.8
Scientific Background
Radicicol inhibits src (IC50=0.27µM) and src-like kinases(1), leading to hypophosphorylation of retinoblastoma tumor suppressor protein(2). It causes morphological reversion of ras-transformed cells(3) and leads to selective depletion of Raf kinase(4). It also displays anti-angiogenic activity(5), and binds to and inhibits Hsp 90 molecular chaperone(6). It binds more strongly to Hsp90 than to GRP94. It also binds to yeast HSP90, E. coli HtpG and TRAP-1. Looking for more information on HSP90? Visit our new HSP90 Scientific Resource Guide at http://www.HSP90.ca.
Solubility
Soluble in DMSO
Source
Produced by fermentation
Adr Code
Non-hazardous
Country Of Origin
Canada
Tarriff Code
3822.00.1090
Shipping Temperature
Shipped Ambient
Gross Weight (kg)
0.25
Net Weight (g)
0.001
Purity
97% by TLC
Storage Temperature
-20ºC
Stock Product
Y
Reference
1. Kwon H.J., et al. (1992) Cancer Res. 52: 6929. 2. Yen A., et al. (1994) Exp.Cell Res. 214: 163. 3. Kwon H.J., et al. (1995) J.Biochem.(Tokyo) 118: 221. 4. Soga S., et al. (1998) J.Biol.Chem. 273: 822. 5. Oikawa T., et al. (1993) Eur.J.Pharmacol. 241: 221. 6. Roe S.M. et al. (1999) J.Med.Chem. 42: 260.